Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

63
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
63
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent Advances in Hydrogels for Tissue Engineering Applications.

Gels (Basel, Switzerland)·2026
Same author

Decoding the Heart Through Computed Tomography: Early Cardiomyopathy Detection Using Ensemble-Based Segmentation and Radiomics.

Journal of imaging·2026
Same author

In Vitro Assessment of a Doubly Adjuvanted Self-Emulsified Nanoemulsion as a Delivery Vehicle for Antigenic Proteins.

Pharmaceutics·2025
Same author

Quantum algorithm for protein-ligand docking sites identification in the interaction space.

Journal of computer-aided molecular design·2025
Same author

Genome-wide functional annotation of variants: a systematic review of state-of-the-art tools, techniques and resources.

Frontiers in pharmacology·2025
Same author

Deep learning for cardiac imaging: focus on myocardial diseases, a narrative review.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2024

Related Experiment Video

Updated: Mar 3, 2026

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

1.3K

Recent developments in nanocarrier-aided mucosal vaccination.

Olga Kammona1, Vassilis Bourganis2, Theodora Karamanidou2

  • 1Chemical Process & Energy Resources Institute, Centre for Research & Technology Hellas, PO Box 60361, 57001 Thessaloniki, Greece.

Nanomedicine (London, England)
|April 26, 2017
PubMed
Summary

Developing safe, nonviral nanocarriers for mucosal vaccines is crucial. These advanced systems aim to enhance immune responses and overcome limitations of current live-attenuated viral vaccines.

Keywords:
adjuvantsmucosal vaccinationnanocarrierspolymeric nanoparticlesvesicles

More Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Related Experiment Videos

Last Updated: Mar 3, 2026

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

1.3K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Area of Science:

  • Vaccinology
  • Nanotechnology
  • Immunology

Background:

  • Current mucosal vaccines often use live-attenuated viruses, posing risks of pathogenicity.
  • Developing effective nonviral vectors is a significant scientific and commercial challenge.

Purpose of the Study:

  • To address the need for safe and potent nonviral vectors for mucosal vaccine delivery.
  • To overcome the limitations of existing mucosal vaccine technologies.

Main Methods:

  • Designing nanocarriers to protect antigens from mucosal degradation.
  • Engineering nanocarriers for efficient antigen uptake by microfold cells.
  • Incorporating safe mucosal adjuvants for co-presentation to antigen-presenting cells.

Main Results:

  • Nanocarriers offer protection against mucosal enzymes.
  • Facilitate antigen uptake and immune cell interaction.
  • Potential for accurate dose administration, improving upon current mucosal vaccine drawbacks.

Conclusions:

  • Nonviral nanocarriers represent a promising platform for next-generation mucosal vaccines.
  • These systems can induce robust humoral and cell-mediated immunity safely.
  • Overcoming dose accuracy issues is key for clinical translation.